Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 07, 2026 03:25 ET | Source: Angelini Pharma; Catalyst Pharmaceuticals

Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease

Angelini Pharma has entered into a definitive agreement to acquire Catalyst Pharmaceuticals.